Sanofi and Teva Unveil Strong Phase 2b Data for Duvakitug, Offering New Hope for IBD Patients 2 years ago AnaIn BreakthroughsClinical Trials
Roche Unveils Breakthrough Sequencing by Expansion Technology That Could Transform Clinical Genomics 2 years ago AnaIn Biopharma HighlightsResearch Updates
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships 2 years ago AnaIn DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences 2 years ago AnaIn AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage 2 years ago AnaIn Industry ConferencesLeadersPeople
FDA Greenlights Merilog—the First Insulin Aspart Biosimilar—Boosting Access and Competition in Diabetes Care 2 years ago AnaIn Breaking NewsClinical TrialsFDA Approvals
FDA Approves Vimseltinib (Romvimza) for Tenosynovial Giant Cell Tumor—A Targeted Therapy First 2 years ago AnaIn Biopharma HighlightsBreakthroughsFDA Approvals
FDA Clears Innovative SPN-830 Apomorphine Infusion System for Advanced Parkinson’s Disease 2 years ago AnaIn FDA ApprovalsInnovationTechnology
FDA Clears First-ever Pentavalent Meningococcal Vaccine—A New Era in Preventing Invasive Meningococcal Disease 2 years ago AnaIn DealsFDA ApprovalsPharma Industry Updates
UK Advances Clinical Trial Landscape: Historic Regulation Reform Paves Way for Efficiency and Inclusivity 2 years ago AnaIn BreakthroughsClinical Trials
Final Analysis of TROPION-Breast01 Reveals No Overall Survival Benefit for Dato-DXd in HR+/HER2– Breast Cancer, Despite PFS Gains 2 years ago AnaIn Research UpdatesTop Stories
India Poised to Become Major Hub for Early-Stage Clinical Trials Amid Global Shifts 2 years ago AnaIn Breaking NewsClinical Trials
Grace Therapeutics’ GTx-104 IV Nimodipine Formulation Reduces Hypotension and ICU Burden in Aneurysmal Subarachnoid Hemorrhage Phase III Trial 2 years ago AnaIn Biopharma HighlightsBreaking NewsTop Stories
Acadia’s Remlifanserin Nears Phase III Completion for Alzheimer’s Disease Psychosis 2 years ago AnaIn Breaking NewsClinical TrialsDeals
Personalized Neoantigen Vaccine Induces Durable Remission in Advanced Kidney Cancer 2 years ago AnaIn DealsFDA ApprovalsResearch Updates
